Oramed Pharmaceuticals, Inc. (OQ:ORMP)

Business Focus: Biotechnology & Medical Research

Latest 10 SEC filings (by transaction date) for ORMP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 18th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 16/19 Sep 16/19 Hexter Joshua Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sep 16/19 Sep 12/19 Rakin Kevin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,000  
Sep 16/19 Sep 12/19 Kidron Nadav Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 196,500  
Sep 16/19 Sep 12/19 Kidron Miriam Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 104,000  
Sep 16/19 Sep 12/19 Gabay Avraham Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 33,146  
Sep 16/19 Sep 12/19 Hexter Joshua Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Sep 11/19 Sep 9/19 Sank Leonard Direct Ownership Common Stock P - Open market or private purchase 10,000 $2.95
Sep 11/19 Sep 9/19 Sank Leonard Direct Ownership Common Stock P - Open market or private purchase 15,000 $2.90
Jul 19/19 Jul 19/19 Xiaoming Gao Indirect Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Jul 18/19 Jul 18/19 Sank Leonard Direct Ownership Common Stock P - Open market or private purchase 4,497 $3.86
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ORMP within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET September 18th, 2019
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Sep 16/19 Sep 12/19 Rakin Kevin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 10,000  
Sep 16/19 Apr 10/19 Rakin Kevin Direct Ownership Stock Option (right to buy) D - Disposition to issuer under Rule 16b-3(e) -10,000  
Sep 16/19 Sep 12/19 Kidron Nadav Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 196,500  
Sep 16/19 Feb 26/19 Kidron Nadav Direct Ownership Stock Option (right to buy) D - Disposition to issuer under Rule 16b-3(e) -196,500  
Sep 16/19 Sep 12/19 Kidron Miriam Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 104,000  
Sep 16/19 Feb 26/19 Kidron Miriam Direct Ownership Stock Option (right to buy) D - Disposition to issuer under Rule 16b-3(e) -104,000  
Sep 16/19 Sep 12/19 Gabay Avraham Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) 33,146  
Sep 16/19 Jun 17/19 Gabay Avraham Direct Ownership Stock Option (right to buy) D - Disposition to issuer under Rule 16b-3(e) -33,146  
Sep 16/19 Sep 12/19 Hexter Joshua Direct Ownership Stock option (right to buy) A - Grant, award or other under Rule 16b-3(d) 100,000  
Sep 16/19 Sep 16/19 Hexter Joshua Direct Ownership Common Stock Form 3 : Initial Statement of Beneficial Ownership of Securities    
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now
Comment On!
140

Twitter

Search (past week) for $ORMP

StockTwits